Vertex Pharmaceuticals

+$1.20 (+0.60%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

CEO

Reshma Kewalramani

Employees

3,400

Headquarters

Boston, Massachusetts

Founded

1989

VRTX Key Statistics

Market Cap

54.98B

Price-Earnings Ratio

19.21

Dividend Yield

—

Average Volume

2.15M

High Today

$203.45

Low Today

$197.31

Open Price

$201.35

Volume

2.13M

52 Week High

$283.45

52 Week Low

$185.33

VRTX News

BenzingaJul 30

Expert Ratings for Vertex Pharmaceuticals - Vertex Pharmaceuticals

Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months A

BenzingaJul 29

Vertex Pharmaceuticals: Q2 Earnings Insights

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) decreased 0.9% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per sh

BenzingaJul 29

Understanding Vertex Pharmaceuticals's Unusual Options Activity

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to

Analyst Ratings

78%

of 27 ratings

Buy

77.8%

Hold

22.2%

Sell

VRTX Earnings

$1.20

$1.84

$2.47

$3.11

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

$2.28 per share

Actual

$3.11 per share

Replay Earnings Call